Raymond Goodrich
Professor Microbiology, Immunology, and PathologyAbout Raymond
Dr. Goodrich holds a faculty appointment as a tenured Professor in the Department of Microbiology, Immunology and Pathology at Colorado State University and an adjunct position as a Professor of Chemistry at The Ohio State University.
Dr. Goodrich has worked in medical research for over 37 years in the fields of transfusion, transplantation medicine, and pathogen reduction technologies. As the former Executive Director of the Infectious Disease Research Center (2016-2023), Dr. Goodrich had responsibility for oversight of the Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC), the Regional Biocontainment Labs (RBL) and the Research Innovation Center (RIC) at Colorado State University.
He formerly served as the Chief Scientific Officer and Vice President of Scientific and Clinical Affairs for Terumo BCT, a medical device company based in Lakewood, Colorado. His most recent work funded by the NIH, Biomedical Advanced Research and Development Authority and Department of Defense is focused on the development of new methods and processes for vaccine production and the development of cancer immunotherapy platforms. He is a member of the Board of Directors of the Association for the Advancement of Blood and Biotherapies (AABB) and serves as a special government employee in the Department of Health and Human Services as a member of the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA). He also serves as an Associate Editor of the journal Frontiers in Immunology.
Dr. Goodrich is a 2018 honorary recipient of the Order of Military Medical Merit (O2M3) for his work on programs of importance to the US Army Medical Command. He has also been recognized by Colorado State University with the CSU Ventures Award for Innovative Excellence in 2021 in recognition of his leadership activities during the COVID pandemic in bringing new technologies and capabilities to bear in addressing public health. He holds over 50 patents and has co-authored 200 peer-reviewed publications. He is an inventor of the Mirasol™ PRT, Innocell™ and SolaVAX™ technology platforms and the co-founder of 4 biotech startup companies during his career.